Stock OEC ORION S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Orion S.A.

Equities

OEC

LU1092234845

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
23.72 USD +0.38% Intraday chart for Orion S.A. -1.54% -14.46%
Apr. 26 Equinox Gold Brief: National Bank Says Updated Its Estimates after Equinox Announced a Bought Deal Offering and New Term Loan to Finance US$995 Mln Acquisition of Orion's 40% interest in Greenstone MT
Apr. 26 Equinox Gold Closes $299 Million Stock Sale With Underwriters Exercising Over-Allotment Option MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,162 1,037 1,113 1,083 1,610 1,373 - -
Enterprise Value (EV) 1 1,754 1,710 1,830 1,938 2,386 2,147 2,148 2,145
P/E ratio 13.6 x 57.1 x 8.31 x 10.3 x 16 x 12.9 x 10.5 x -
Yield 4.15% 1.17% 0.11% 0.45% - 0.38% 0.42% 0.45%
Capitalization / Revenue 0.79 x 0.91 x 0.72 x 0.53 x 0.85 x 0.69 x 0.65 x 0.6 x
EV / Revenue 1.19 x 1.51 x 1.18 x 0.95 x 1.26 x 1.08 x 1.02 x 0.94 x
EV / EBITDA 6.56 x 8.55 x 6.83 x 6.21 x 7.18 x 6.19 x 5.64 x 5.29 x
EV / FCF 23.2 x -87 x -26.3 x -12.8 x 13.8 x 45.8 x 44.7 x 36.4 x
FCF Yield 4.31% -1.15% -3.8% -7.84% 7.25% 2.18% 2.23% 2.75%
Price to Book 6.25 x 5.73 x 3.48 x 2.35 x 3.36 x 2.49 x 2.12 x 1.89 x
Nbr of stocks (in thousands) 60,212 60,487 60,633 60,816 58,044 57,899 - -
Reference price 2 19.30 17.14 18.36 17.81 27.73 23.72 23.72 23.72
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,476 1,136 1,547 2,031 1,894 1,980 2,108 2,276
EBITDA 1 267.3 200 268 312.3 332.3 346.9 380.6 405.8
EBIT 1 170.6 103.5 163.9 206.6 219.3 230.3 259.1 287.7
Operating Margin 11.56% 9.11% 10.6% 10.17% 11.58% 11.63% 12.29% 12.64%
Earnings before Tax (EBT) 1 119.6 25.8 185.7 157.2 163.3 156.6 191.3 -
Net income 1 86.92 18.16 134.7 106.2 103.5 109.2 134.3 -
Net margin 5.89% 1.6% 8.71% 5.23% 5.46% 5.52% 6.37% -
EPS 2 1.420 0.3000 2.210 1.730 1.730 1.840 2.260 -
Free Cash Flow 1 75.66 -19.66 -69.5 -152 173.1 46.87 48 59
FCF margin 5.12% -1.73% -4.49% -7.48% 9.14% 2.37% 2.28% 2.59%
FCF Conversion (EBITDA) 28.3% - - - 52.09% 13.51% 12.61% 14.54%
FCF Conversion (Net income) 87.04% - - - 167.25% 42.92% 35.74% -
Dividend per Share 2 0.8000 0.2000 0.0207 0.0800 - 0.0894 0.0991 0.1065
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 393.1 392.7 484.5 541.2 543.1 462.1 500.7 458.8 466.2 468.2 506.4 476.6 503.1 502.1 542.7
EBITDA 1 66.42 52.3 83.2 83.4 80.5 65.2 101.1 87 77.3 66.6 80.03 87.38 92.55 86.79 94.31
EBIT 1 42.61 22.8 55.9 56 55.3 39.4 75.4 59.8 49.4 34.4 54.75 56.21 62.06 55.39 65.05
Operating Margin 10.84% 5.81% 11.54% 10.35% 10.18% 8.53% 15.06% 13.03% 10.6% 7.35% 10.81% 11.79% 12.34% 11.03% 11.99%
Earnings before Tax (EBT) 1 27.62 4.1 46.2 - 43.4 25.2 60.5 47.7 35 20.1 31 41.6 48.2 35.8 46.4
Net income 1 21.01 1.1 32.5 - 31.8 12.2 42.3 30.1 26.2 4.9 21.7 29 33.6 25 32.6
Net margin 5.35% 0.28% 6.71% - 5.86% 2.64% 8.45% 6.56% 5.62% 1.05% 4.28% 6.08% 6.68% 4.98% 6.01%
EPS 2 0.3500 0.0100 0.5300 - 0.5200 0.2000 0.7000 0.5100 0.4400 0.0800 0.3700 0.4900 0.5700 0.4200 0.5500
Dividend per Share 2 - - 0.0207 0.0200 0.0200 0.0200 0.0200 0.0200 - - 0.0223 0.0223 0.0223 0.0223 0.0245
Announcement Date 11/4/21 2/17/22 5/5/22 8/4/22 11/3/22 2/16/23 5/4/23 8/9/23 11/2/23 2/14/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 592 674 717 855 777 773 774 772
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.213 x 3.367 x 2.676 x 2.738 x 2.338 x 2.23 x 2.035 x 1.902 x
Free Cash Flow 1 75.7 -19.7 -69.5 -152 173 46.9 48 59
ROE (net income / shareholders' equity) 65.1% 34.1% 42% 27.3% 24.6% 24.9% 24.7% 24.2%
ROA (Net income/ Total Assets) 8.87% 4.73% 8.92% 6.03% 6.2% 6.72% 7.07% 7.4%
Assets 1 979.7 383.8 1,510 1,760 1,671 1,625 1,899 -
Book Value Per Share 2 3.090 2.990 5.270 7.580 8.260 9.530 11.20 12.60
Cash Flow per Share - - - - - - - -
Capex 1 156 145 215 233 173 197 185 163
Capex / Sales 10.56% 12.75% 13.88% 11.46% 9.12% 9.93% 8.78% 7.14%
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Orion S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
23.72 USD
Average target price
29.5 USD
Spread / Average Target
+24.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ORION S.A. Stock Orion S.A.
-14.46% 1.37B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. OEC Stock
  4. Financials Orion S.A.